...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Reply from Sarah

BDAZ, thanks for your insight, balance and persistence. In order for this site to continue to be of value it requires persistent, objective critical thinking and reasoning based on each person's experiences and insights.

I agree with you completely regarding Sarah. I have the same experiences with her responses. However, see your mail box. I sent you a perspective re Sarah/sources of info.

One way to view Sarah's reply is that there is much more to be learned from what her response did not say. I can't speculate on all of the inferences but one implication is that there is something (perhaps big) coming up???

GLTA

Toinv

Share
New Message
Please login to post a reply